The SELECT trial randomized 8803 patients with obesity (body mass index, 27 kg/m 2 ), established cardiovascular disease, and no diabetes to semaglutide versus 8801 patients to placebo with the primary outcome of major adverse cardiovascular events
Semaglutide is one of the most effective glucagon-like peptide-1 agonizts for the management of obesity and metabolic diseases, but little is known about its effect on the long-term health of offspring
Preoperative Assessment Preoperative medication reconciliation should explicitly include incretin therapy
That reduced appetite, if not overseen properly by a doctor, could cause nutritional deficiencies and leave people with less energy for workouts, says Dr
Understanding Glutathione: The Skin's Best Friend Before diving into the debate of tablets versus injections, let's first understand what glutathione is and why it has gained such prominence in the world of skincare
Sometimes the odor is not coming from urine itself